- Home
- ELVA vs XTNT Comparison
ELVA vs XTNT Comparison
Compare ELVA & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVA
- XTNT
- Stock Information
- Founded
- ELVA 1996
- XTNT N/A
- Country
- ELVA Canada
- XTNT United States
- Employees
- ELVA N/A
- XTNT N/A
- Industry
- ELVA
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ELVA
- XTNT Health Care
- Exchange
- ELVA Nasdaq
- XTNT Nasdaq
- Market Cap
- ELVA 91.8M
- XTNT 83.2M
- IPO Year
- ELVA N/A
- XTNT N/A
- Fundamental
- Price
- ELVA $2.29
- XTNT $0.59
- Analyst Decision
- ELVA Strong Buy
- XTNT Strong Buy
- Analyst Count
- ELVA 5
- XTNT 1
- Target Price
- ELVA $6.70
- XTNT $3.00
- AVG Volume (30 Days)
- ELVA 71.7K
- XTNT 50.3K
- Earning Date
- ELVA 02-13-2025
- XTNT 03-31-2025
- Dividend Yield
- ELVA N/A
- XTNT N/A
- EPS Growth
- ELVA N/A
- XTNT N/A
- EPS
- ELVA N/A
- XTNT N/A
- Revenue
- ELVA $43,693,000.00
- XTNT $113,862,000.00
- Revenue This Year
- ELVA $55.29
- XTNT $31.27
- Revenue Next Year
- ELVA $58.94
- XTNT $13.07
- P/E Ratio
- ELVA N/A
- XTNT N/A
- Revenue Growth
- ELVA N/A
- XTNT 45.11
- 52 Week Low
- ELVA $1.67
- XTNT $0.33
- 52 Week High
- ELVA $4.24
- XTNT $1.30
- Technical
- Relative Strength Index (RSI)
- ELVA 39.90
- XTNT 52.36
- Support Level
- ELVA $2.45
- XTNT $0.55
- Resistance Level
- ELVA $2.60
- XTNT $0.62
- Average True Range (ATR)
- ELVA 0.16
- XTNT 0.05
- MACD
- ELVA -0.02
- XTNT -0.01
- Stochastic Oscillator
- ELVA 31.58
- XTNT 41.76
About ELVA Electrovaya Inc.
Electrovaya Inc designs develop and manufacture proprietary lithium-ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation and other specialized applications. It is a technology-focused company with extensive IP. The company generates revenue from the sale of batteries and battery systems. Business operations are segmented based on large format batteries and others. This technology offers enhanced safety and battery longevity. Geographically it earns key revenue from the United States.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.